Resmed (Australia) Analysis

RMD Stock   36.76  0.21  0.57%   
Resmed Inc DRC is fairly valued with Real Value of 36.91 and Hype Value of 36.78. The main objective of Resmed stock analysis is to determine its intrinsic value, which is an estimate of what Resmed Inc DRC is worth, separate from its market price. There are two main types of Resmed's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Resmed's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Resmed's stock to identify patterns and trends that may indicate its future price movements.
The Resmed stock is traded in Australia on Australian Securities Exchange, with the market opening at 09:50:00 and closing at 16:12:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Australia. Resmed is usually not traded on Christmas Day, Boxing Day, New Year 's Day, Australia Day, Australia Day ( substitute day ), Good Friday, Easter Monday, ANZAC Day. Resmed Stock trading window is adjusted to Australia/Sydney timezone.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Resmed Inc DRC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Resmed Stock Analysis Notes

The company has Price/Earnings To Growth (PEG) ratio of 1.73. Resmed Inc DRC last dividend was issued on the 6th of November 2024. The entity had 2:1 split on the 12th of August 2010. To find out more about Resmed Inc DRC contact BE MBA at 858-836-5000 or learn more at https://www.resmed.com.

Resmed Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 54.15 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Resmed's market, we take the total number of its shares issued and multiply it by Resmed's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Resmed Profitablity

Resmed's profitability indicators refer to fundamental financial ratios that showcase Resmed's ability to generate income relative to its revenue or operating costs. If, let's say, Resmed is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Resmed's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Resmed's profitability requires more research than a typical breakdown of Resmed's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.23 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.32 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.32.

Technical Drivers

As of the 6th of January, Resmed holds the Risk Adjusted Performance of 0.0678, semi deviation of 1.23, and Coefficient Of Variation of 1285.83. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Resmed, as well as the relationship between them.

Resmed Inc DRC Price Movement Analysis

Execute Study
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Resmed middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Resmed Inc DRC. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Resmed Outstanding Bonds

Resmed issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Resmed Inc DRC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Resmed bonds can be classified according to their maturity, which is the date when Resmed Inc DRC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Resmed Predictive Daily Indicators

Resmed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Resmed stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Resmed Forecast Models

Resmed's time-series forecasting models are one of many Resmed's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Resmed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Resmed to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Fundamental Analysis Now

   

Fundamental Analysis

View fundamental data based on most recent published financial statements
All  Next Launch Module

Additional Tools for Resmed Stock Analysis

When running Resmed's price analysis, check to measure Resmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Resmed is operating at the current time. Most of Resmed's value examination focuses on studying past and present price action to predict the probability of Resmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Resmed's price. Additionally, you may evaluate how the addition of Resmed to your portfolios can decrease your overall portfolio volatility.